75 related articles for article (PubMed ID: 15896776)
1. Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
Cook AL; Smith AG; Smit DJ; Leonard JH; Sturm RA
Exp Cell Res; 2005 Aug; 308(1):222-35. PubMed ID: 15896776
[TBL] [Abstract][Full Text] [Related]
2. The EJC component Magoh regulates proliferation and expansion of neural crest-derived melanocytes.
Silver DL; Leeds KE; Hwang HW; Miller EE; Pavan WJ
Dev Biol; 2013 Mar; 375(2):172-81. PubMed ID: 23333945
[TBL] [Abstract][Full Text] [Related]
3. A gene regulatory network combining Pax3/7, Sox10 and Mitf generates diverse pigment cell types in medaka and zebrafish.
Miyadai M; Takada H; Shiraishi A; Kimura T; Watakabe I; Kobayashi H; Nagao Y; Naruse K; Higashijima SI; Shimizu T; Kelsh RN; Hibi M; Hashimoto H
Development; 2023 Oct; 150(19):. PubMed ID: 37823232
[TBL] [Abstract][Full Text] [Related]
4. Comparison of melanoblast expression patterns identifies distinct classes of genes.
Loftus SK; Baxter LL; Buac K; Watkins-Chow DE; Larson DM; Pavan WJ
Pigment Cell Melanoma Res; 2009 Oct; 22(5):611-22. PubMed ID: 19493314
[TBL] [Abstract][Full Text] [Related]
5. Enhanced quality of hESC-derived melanocytes through modified concentration of endothelin-1.
Zeng X; Lv H; Jin Y; Liu Y; Wang J; Lian W; Huang S; Shen J; Wu F; Zhang Q; Xu J
Exp Dermatol; 2024 Jan; 33(1):e15004. PubMed ID: 38284190
[TBL] [Abstract][Full Text] [Related]
6. SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death.
Rosenbaum SR; Caksa S; Stefanski CD; Trachtenberg IV; Wilson HP; Wilski NA; Ott CA; Purwin TJ; Haj JI; Pomante D; Kotas D; Chervoneva I; Capparelli C; Aplin AE
Mol Cancer Res; 2024 Feb; 22(2):209-220. PubMed ID: 37847239
[TBL] [Abstract][Full Text] [Related]
7. A zebrafish system for identifying genetic dependencies in melanocytes and melanoma.
Perlee S; Ma Y; Hunter MV; Swanson JB; Ming Z; Xia J; Lionnet T; McGrail M; White R
bioRxiv; 2024 Mar; ():. PubMed ID: 38562693
[TBL] [Abstract][Full Text] [Related]
8. Learning from Embryogenesis-A Comparative Expression Analysis in Melanoblast Differentiation and Tumorigenesis Reveals miRNAs Driving Melanoma Development.
Linck-Paulus L; Lämmerhirt L; Völler D; Meyer K; Engelmann JC; Spang R; Eichner N; Meister G; Kuphal S; Bosserhoff AK
J Clin Med; 2021 May; 10(11):. PubMed ID: 34073664
[TBL] [Abstract][Full Text] [Related]
9. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
[TBL] [Abstract][Full Text] [Related]
10. Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall.
Rao P; Fuller GN; Prieto VG
Am J Dermatopathol; 2010 May; 32(3):262-266. PubMed ID: 20098296
[TBL] [Abstract][Full Text] [Related]
11. Whole Genome Resequencing Reveals Selection Signals Related to Wool Color in Sheep.
Zhang W; Jin M; Lu Z; Li T; Wang H; Yuan Z; Wei C
Animals (Basel); 2023 Oct; 13(20):. PubMed ID: 37893989
[TBL] [Abstract][Full Text] [Related]
12. Sox9 regulates melanocytic fate decision of adult hair follicle stem cells.
Stüfchen I; Beyer F; Staebler S; Fischer S; Kappelmann M; Beckervordersandforth R; Bosserhoff AK
iScience; 2023 Jun; 26(6):106919. PubMed ID: 37283806
[TBL] [Abstract][Full Text] [Related]
13. BRN2 is a non-canonical melanoma tumor-suppressor.
Hamm M; Sohier P; Petit V; Raymond JH; Delmas V; Le Coz M; Gesbert F; Kenny C; Aktary Z; Pouteaux M; Rambow F; Sarasin A; Charoenchon N; Bellacosa A; Sanchez-Del-Campo L; Mosteo L; Lauss M; Meijer D; Steingrimsson E; Jönsson GB; Cornell RA; Davidson I; Goding CR; Larue L
Nat Commun; 2021 Jun; 12(1):3707. PubMed ID: 34140478
[TBL] [Abstract][Full Text] [Related]
14. Gestational folate deficiency alters embryonic gene expression and cell function.
Seelan RS; Mukhopadhyay P; Philipose J; Greene RM; Pisano MM
Differentiation; 2021; 117():1-15. PubMed ID: 33302058
[TBL] [Abstract][Full Text] [Related]
15. A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF
Smith MP; Rana S; Ferguson J; Rowling EJ; Flaherty KT; Wargo JA; Marais R; Wellbrock C
Pigment Cell Melanoma Res; 2019 Mar; 32(2):280-291. PubMed ID: 30277012
[TBL] [Abstract][Full Text] [Related]
16. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
[TBL] [Abstract][Full Text] [Related]
17. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
[TBL] [Abstract][Full Text] [Related]
18. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
[TBL] [Abstract][Full Text] [Related]
19. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
Wellbrock C; Arozarena I
Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
